All change for home oxygen services in England and Wales

Wedzicha, JA

doi:10.1136/thx.2005.056192

Cited by 5 publications

(2 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Oxygen, when prescribed as clinical therapy, should be considered to be a drug (Joint Formulary Committee 2017); documented risks of oxygen therapy include increased damage to lung function, which is potentially fatal in susceptible patients, and discomfort (Uronis et al 2008, Clemens et al 2009, Jaturapatporn et al 2010, Uronis et al 2014, psychological dependency, anxiety and altered self-image (Uronis et al 2008) and reduced mobility and participation in social activities (Uronis et al 2008, Jaturapatporn et al 2010, Breaden et al 2013, Collier et al 2017. However in the United Kingdom (UK), although oxygen has to be prescribed for home use, there is no national requirement for this to be undertaken by a qualified prescriber or specialist; it can be initiated by non-specialist health care professionals, as agreed by local protocol, and can be initiated in both primary and secondary care (Wedzicha & Calverley 2006) with follow-up and review services managed locally, although recommendations for this process are available (NHS Primary Care Commissioning 2011). There are published guidelines and prescription criteria for both emergency oxygen (O'Driscoll et al 2017) and home oxygen (Hardinge et al 2015) but these primarily focus on its use for treatment and symptom management in hypoxaemic patients, that is patients with a resting PaO2 ≤7.3 kPa or ≤8.0 kPa with other complications (Hardinge et al 2015); the guidelines are less clear for non-hypoxaemic palliative patients.…”

Section: Introductionmentioning

confidence: 99%

Literature review of clinical benefits and reasons to prescribe palliative oxygen therapy in non-hypoxaemic patients

Collis

2018

Br J Nurs

View full text Add to dashboard Cite

Aims. To review current guidelines and studies available to health care professionals in the United Kingdom and explore the literature to identify reasons for the prescription of palliative oxygen therapy in non-hypoxaemic patients. Background. Oxygen therapy is often associated with the palliative treatment for breathlessness. Although prescription guidelines are available and risks of oxygen therapy are known the therapy is still prescribed for non-hypoxaemic patients. Design. A literature search was conducted using relevant databases. Cited evidence from published guidelines was also consulted. Results. The findings suggests that oxygen is no more effective than room air for treating dyspnoea for nonhypoxaemic patients although two small studies of self-reported benefits from patients and carers indicate different perceptions of need. Conclusion. The findings suggest a knowledge gap with regards understanding the reasons for the prescription of oxygen therapy in non-hypoxaemic patients.

show abstract

Section: Introductionmentioning

confidence: 99%

Literature review of clinical benefits and reasons to prescribe palliative oxygen therapy in non-hypoxaemic patients

Collis

2018

Br J Nurs

View full text Add to dashboard Cite

show abstract

“…A new national home oxygen service for England and Wales was introduced in February 2006, which awarded four companies contracts to provide all the necessary equipment for 11 oxygen regions 3 4. Ordering was done using a standard Home Oxygen Order Form (HOOF), available from the Department of Health and on the British Paediatric Respiratory Society website (http://www.bprs.co.uk/oxygen.html).…”

mentioning

confidence: 99%